Anil Oza is a general assignment reporter at STAT focused on the NIH and health equity. You can reach him on Signal at aniloza.16. In 2022, Noha Aboelata noticed something troubling. The founding CEO ...

One-year data from Boston Scientific’s FARADISE registry demonstrated the strong efficacy of its Farapulse PFA system yet ...

Pulse Biosciences will study PFA in cardiac surgery. Meanwhile, Galvanize Therapeutics also named a new CEO, and PFA pioneer ...

Imagine tracking your heartbeat without strapping on a smartwatch or touching any gadget, just by sitting within range of ...

Pulse Biosciences says the FDA granted investigational device exemption (IDE) for its nanosecond pulsed field ablation (nsPFA ...

-One of healthcare’s most fundamental tools works less reliably for people with darker skin tones. - An Oakland clinic’s lawsuit is helping to change that in California. The pulse oximeter, a device ...

The U.S. Food and Drug Administration is seeking public comment on new recommendations for nonclinical and clinical performance testing to support premarket submissions for pulse oximeters for medical ...

The trial will evaluate the effectiveness of the nsPFA cardiac surgical system during concurrent surgical procedures.

The new system, called Pulse-Fi, transforms ordinary wireless signals into health trackers. It promises a future where people ...